- Home
- RGNX vs IGD Comparison
RGNX vs IGD Comparison
Compare RGNX & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- IGD
- Stock Information
- Founded
- RGNX 2008
- IGD N/A
- Country
- RGNX United States
- IGD United States
- Employees
- RGNX N/A
- IGD N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- IGD Trusts Except Educational Religious and Charitable
- Sector
- RGNX Health Care
- IGD Finance
- Exchange
- RGNX Nasdaq
- IGD Nasdaq
- Market Cap
- RGNX 387.0M
- IGD 422.7M
- IPO Year
- RGNX 2015
- IGD N/A
- Fundamental
- Price
- RGNX $8.18
- IGD $5.63
- Analyst Decision
- RGNX Strong Buy
- IGD
- Analyst Count
- RGNX 8
- IGD 0
- Target Price
- RGNX $31.75
- IGD N/A
- AVG Volume (30 Days)
- RGNX 1.2M
- IGD 215.3K
- Earning Date
- RGNX 05-12-2025
- IGD 01-01-0001
- Dividend Yield
- RGNX N/A
- IGD 9.15%
- EPS Growth
- RGNX N/A
- IGD N/A
- EPS
- RGNX N/A
- IGD N/A
- Revenue
- RGNX $156,718,000.00
- IGD N/A
- Revenue This Year
- RGNX $285.14
- IGD N/A
- Revenue Next Year
- RGNX N/A
- IGD N/A
- P/E Ratio
- RGNX N/A
- IGD N/A
- Revenue Growth
- RGNX 80.70
- IGD N/A
- 52 Week Low
- RGNX $5.04
- IGD $4.60
- 52 Week High
- RGNX $17.52
- IGD $5.26
- Technical
- Relative Strength Index (RSI)
- RGNX 51.88
- IGD 56.59
- Support Level
- RGNX $6.89
- IGD $5.58
- Resistance Level
- RGNX $10.59
- IGD $5.62
- Average True Range (ATR)
- RGNX 0.76
- IGD 0.06
- MACD
- RGNX -0.16
- IGD 0.01
- Stochastic Oscillator
- RGNX 34.86
- IGD 89.13
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.